Zhejiang Jingxin Pharmaceutical Co Ltd (002020) — Cash Flow Quality Index
Zhejiang Jingxin Pharmaceutical Co Ltd (002020) has a Cash Flow Quality Index of 1.21x as of September 2025. Operating cash flow of CN¥227.64 Million exceeds net income of CN¥187.73 Million, indicating high earnings quality where cash backs reported profits. Explore how much of Zhejiang Jingxin Pharmaceutical Co Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Zhejiang Jingxin Pharmaceutical Co Ltd Cash Flow Quality Index (2002–2025)
Historical Cash Flow Quality Index for Zhejiang Jingxin Pharmaceutical Co Ltd across 23 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 002020 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Zhejiang Jingxin Pharmaceutical Co Ltd (2002–2025)
Year-by-year earnings quality comparison for Zhejiang Jingxin Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see 002020 company net worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.03x | CN¥781.35 Million | CN¥757.98 Million | ▲ +2.1% |
| 2024 | 1.01x | CN¥726.16 Million | CN¥719.13 Million | ▼ -23.7% |
| 2023 | 1.32x | CN¥824.69 Million | CN¥623.42 Million | ▲ +3.2% |
| 2022 | 1.28x | CN¥855.78 Million | CN¥667.82 Million | ▲ +115.8% |
| 2021 | 0.59x | CN¥365.02 Million | CN¥614.70 Million | ▼ -24.4% |
| 2020 | 0.79x | CN¥513.21 Million | CN¥653.33 Million | ▼ -23.4% |
| 2019 | 1.03x | CN¥535.30 Million | CN¥521.95 Million | ▼ -27.2% |
| 2018 | 1.41x | CN¥523.40 Million | CN¥371.49 Million | ▼ -2.3% |
| 2017 | 1.44x | CN¥385.01 Million | CN¥267.03 Million | ▲ +23.7% |
| 2016 | 1.17x | CN¥252.69 Million | CN¥216.73 Million | ▲ +34.3% |
| 2015 | 0.87x | CN¥144.69 Million | CN¥166.62 Million | ▼ -55.8% |
| 2014 | 1.97x | CN¥210.49 Million | CN¥107.08 Million | ▲ +13.9% |
| 2013 | 1.73x | CN¥111.03 Million | CN¥64.35 Million | ▼ -9.3% |
| 2012 | 1.90x | CN¥60.28 Million | CN¥31.68 Million | ▼ -20.2% |
| 2011 | 2.38x | CN¥69.41 Million | CN¥29.12 Million | ▼ -48.1% |
| 2010 | 4.59x | CN¥59.55 Million | CN¥12.96 Million | ▼ -86.5% |
| 2009 | 34.09x | CN¥135.38 Million | CN¥3.97 Million | ▲ +156.6% |
| 2007 | -60.25x | CN¥-87.60 Million | CN¥1.45 Million | ▼ -43530.9% |
| 2006 | -0.14x | CN¥-1.45 Million | CN¥10.47 Million | ▼ -104.1% |
| 2005 | 3.35x | CN¥61.82 Million | CN¥18.45 Million | ▲ +1243.6% |
| 2004 | 0.25x | CN¥6.43 Million | CN¥25.79 Million | ▼ -86.3% |
| 2003 | 1.82x | CN¥46.18 Million | CN¥25.40 Million | ▼ -11.0% |
| 2002 | 2.04x | CN¥45.50 Million | CN¥22.28 Million | — |